Device Trial Radar · NCT01526681
Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
Last checked: Nov 19, 2026Latest source record: Jan 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
3,126
Actual
Start
Nov 2008
Primary completion
Nov 2028
Study completion Nov 2028
Sponsor
- Lead sponsor
- Axogen CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 6, 2012
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a registry of general use of Avance Nerve Graft and is intended to evaluate the uses, response rates, and safety of Avance Nerve Graft in the real-life clinical setting. Optional addendums 1 and 2 included in the protocol are intended to establish comparative groups and focused subgroups within the registry.
Conditions
- Peripheral Nerve Injuries
Interventions
Processed Human Nerve GraftOther
Implantation of appropriate length of processed human nerve graft at the time of surgery
Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc.Other
Historical control from established literature
Autogenous Nerve GraftOther
Nerve gap reconstructions with autogenous nerve graft within the upper extremity
Nerve Tube ConduitDevice
Nerve gap reconstructions with nerve tube conduit within the upper extremity
Autologous Breast Reconstruction with NeurotizationProcedure
Autologous Breast Reconstruction without NeurotizationProcedure
Primary outcomes
What the sponsor says the trial is designed to measure.
- Avance Nerve Graft: Incidence of Avance Nerve Graft Related Adverse EventsTime frame: Through study completion or until lost to follow-up, approximately 3 years
- RANGER and MATCH: Sensory Function as measured by Medical Research Council Classification (MRCC) for sensory recoveryTime frame: Through study completion or until lost to follow-up, approximately 3 years
- RANGER and MATCH: Motor Function as measured by Medical Research Council Classification (MRCC) for motor recoveryTime frame: Through study completion or until lost to follow-up, approximately 3 years
3 more outcomes with a free account
Locations
49 sites in 4 countries. Site status is shown where the registry gives one.
RANGER & MATCH: Arizona Center for Hand Surgery
Phoenix, Arizona
RANGER: Phoenix Children's Hospital
Phoenix, Arizona
RANGER & MATCH: University of California - Irvine
Orange, California
46 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.